CUA Educational Content

Insights on Early Stage RCC Detection & Emerging Management Strategies

EDITORIAL COMMITTEE: ALY-KHAN LALANI, ANIL KAPOOR, DANIEL HENG, RICARDO RENDON

LEARNING OBJECTIVES:

At the conclusion of this program, participants should be able to:

  • Recognize early RCC disease stage symptoms and underlying risk factors associated with recurrence rates
  • Assess emergent adjuvant RCC clinical trial data and their impact on current clinical practice
  • Identify key patient factors important for the consideration of adjuvant therapy in early stage RCC

 

button

*Please contact rita.demarco@cua.org to request the powerpoint slides. 

Start Quiz for Credits

 

​This program was made possible with financial support from Merck.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy